Related Experiment Video

Updated: May 26, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Operation 'p53 Hunt' to combat cancer: theaflavins in action

Suchismita Mohanty1, Arghya Adhikary, Samik Chakrabarty

  • 1Division of Molecular Medicine, Bose Institute, P1/12 CIT Scheme VIIM, Kolkata, India.

Frontiers in Bioscience (Scholar Edition)
|December 29, 2011
PubMed

Insights

Black tea theaflavins can restore the tumor suppressor p53 (the guardian angel protein) function, offering a safe and effective strategy for cancer therapy by targeting multiple cancer hallmarks and cancer stem cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Phytochemistry

Background:

  • Phytochemicals offer anti-tumor mechanisms, making the p53 protein a critical target for cancer therapeutics.
  • Dietary polyphenols, like black tea theaflavins, are recognized for their efficacy and safety in regulating p53 functions.
  • p53 dysfunction is a common mechanism of cancer development.

Purpose of the Study:

  • To review the complexities of p53 functions and its inactivation in cancer.
  • To explore therapeutic strategies for rescuing p53 dysfunction using theaflavins.
  • To discuss the potential role of theaflavin-p53 interactions in targeting cancer stem cells (CSCs).

Main Methods:

  • Literature review focusing on p53 pathways and theaflavin's molecular mechanisms.
  • Analysis of how theaflavins regulate key hallmarks of carcinogenesis.
  • Exploration of the cross-talk between theaflavins and p53 in the context of CSCs.

Main Results:

  • Theaflavins, by targeting p53, can modulate critical cancer hallmarks including glycolysis, angiogenesis, metastasis, apoptosis, and drug resistance.
  • Theaflavin-p53 interactions show potential for targeting cancer stem cells, which drive tumor evolution.
  • Theaflavins offer a unified approach to target multiple carcinogenic pathways through p53.

Conclusions:

  • Theaflavins represent a promising therapeutic agent for cancer, leveraging the 'guardian angel' p53 pathway.
  • Targeting p53 with theaflavins provides a multi-pronged strategy against cancer hallmarks and CSCs.
  • This approach could lead to novel strategies for cancer prevention and treatment.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.